A study conducted in Thailand of patients with CD4 counts <350 (median baseline CD4 = 43) and active TB found no advantage of early treatment (at 4 weeks) compared with ART initiation at 12 weeks for any measure, including for patients with CD4<50 or CD4 <100 [8]. Here, CD4 is linked to tuberculosis.